# Reactivation of Multidrug-Resistant HSV-1 in a Post–Allogenic Hematopoietic Stem Cell Transplant Patient: Dynamic Detection of the Rare A605V Mutation by Next-Generation Sequencing

**Authors:** Shuxuan Zheng, Lidewij W Rümke, Bruno Tello Rubio, Malbert R C Rogers, Geerte L van Sluis, Jürgen H E Kuball, Annelies Riezebos-Brilman, Robert Jan Lebbink, Frans M Verduyn Lunel

PMC · DOI: 10.1093/ofid/ofae250 · 2024-05-03

## TL;DR

A patient with a weakened immune system experienced a rare drug-resistant herpes virus reactivation, detected using advanced sequencing techniques.

## Contribution

Dynamic detection of a rare HSV-1 mutation (A605V) using next-generation sequencing in an immunocompromised patient.

## Key findings

- Next-generation sequencing identified a rare A605V mutation in the HSV-1 DNA polymerase gene.
- Multiple drug-resistant strains were detected before treatment, with altered ratios observed during treatment.
- The mutation affected the patient's clinical response to aciclovir and foscarnet.

## Abstract

We present an immunocompromised patient with a multiresistant herpes simplex virus–1 reactivation with a rare mutation (A605V) in the viral DNA polymerase gene. Next-generation sequencing suggests the presence of multiple drug-resistant strains before treatment and altered ratios during treatment, affecting the clinical response to aciclovir and foscarnet.

## Linked entities

- **Chemicals:** aciclovir (PubChem CID 135398513), foscarnet (PubChem CID 3415)

## Full-text entities

- **Species:** Homo sapiens (human, species) [taxon 9606], Human alphaherpesvirus 1 (Herpes simplex virus type 1, no rank) [taxon 10298]
- **Mutations:** A605V

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11127484/full.md

---
Source: https://tomesphere.com/paper/PMC11127484